Agenzia Italiana del Farmaco
Home
The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 May 2021 relating to the four vaccines used in the current vaccination campaign.
The new portal for the preparation of dossiers in digital format to support applications for reimbursement and pricing was presented.
La Commissione tecnico scientifica (CTS) dell’AIFA si è espressa sulle modalità di utilizzo della schedula vaccinale mista in soggetti al di sotto dei 60 anni di età che hanno ricevuto una prima dose di vaccino Vaxzevria.
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
Medicines alerts
AIFA Focus
"Do you want to know more about COVID-19 vaccines?"
09 June
09:00 - 19:00
17 June
13:30
18 June
da definire
Competitions
